ZemiARB

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameZemiARB
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes MellitusHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Georgia and the South Sandwich IslandsSouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLg Chemical Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusHypertension

Other Information

ATC CodeN/A
Related LinksN/A